Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Instagram Outage Disrupts Thousands of U.S. Users
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady 



